Investor Relations

Press, quotes, SEC filings, alerts, more.

COVID-19

Launching ARTIVeda™ for COVID-19 in India.

Pipeline

Cancer and viral infection treatment information.

EdgePoint AI

Core cloud-computer AI platform.

Most recent news and events

Oncotelic Happenings

Oncotelic and Windlas ARTIVeda announcement

Oncotelic and Windlas Biotech ready to launch ARTIVeda™ in India to address the COVID pandemic. Learn more >

11 Billion $

target markets

100 Plus

patent applications

2 Key

clinical programs

30 Years

experience

Questions or Comments?

Copyright © 2020 Onteclic Therapeutics Inc., a TGF ImmunoOncology Company. All rights reserved.